BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24730453)

  • 1. Survival after cutaneous melanoma in kidney transplant recipients: a population-based matched cohort study.
    Vajdic CM; Chong AH; Kelly PJ; Meagher NS; Van Leeuwen MT; Grulich AE; Webster AC
    Am J Transplant; 2014 Jun; 14(6):1368-75. PubMed ID: 24730453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma incidence, stage, and survival after solid organ transplant: A population-based cohort study in Ontario, Canada.
    Park CK; Dahlke EJ; Fung K; Kitchen J; Austin PC; Rochon PA; Chan AW
    J Am Acad Dermatol; 2020 Sep; 83(3):754-761. PubMed ID: 32111554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma in a cohort of organ transplant recipients: Experience from a dedicated transplant dermatology clinic in Victoria, Australia.
    Maor D; Vajdic CM; Cumming S; Fahey V; Bala HR; Snaidr V; Brennand S; Goh MSY; Chong AH
    J Am Acad Dermatol; 2020 Sep; 83(3):773-779. PubMed ID: 31706934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.
    Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M;
    JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
    Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
    JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma Risk and Survival among Organ Transplant Recipients.
    Robbins HA; Clarke CA; Arron ST; Tatalovich Z; Kahn AR; Hernandez BY; Paddock L; Yanik EL; Lynch CF; Kasiske BL; Snyder J; Engels EA
    J Invest Dermatol; 2015 Nov; 135(11):2657-2665. PubMed ID: 26270022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of HLA Antigen Mismatch With Risk of Developing Skin Cancer After Solid-Organ Transplant.
    Gao Y; Twigg AR; Hirose R; Roll GR; Nowacki AS; Maytin EV; Vidimos AT; Rajalingam R; Arron ST
    JAMA Dermatol; 2019 Mar; 155(3):307-314. PubMed ID: 30673077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Melanoma in Renal Transplant Recipients.
    Ascha M; Ascha MS; Tanenbaum J; Bordeaux JS
    JAMA Dermatol; 2017 Nov; 153(11):1130-1136. PubMed ID: 28746700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma.
    El Sharouni MA; Aivazian K; Witkamp AJ; Sigurdsson V; van Gils CH; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
    JAMA Dermatol; 2021 Feb; 157(2):166-173. PubMed ID: 33355600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red meat and fruit intake is prognostic among patients with localized cutaneous melanomas more than 1mm thick.
    Gould Rothberg BE; Bulloch KJ; Fine JA; Barnhill RL; Berwick M
    Cancer Epidemiol; 2014 Oct; 38(5):599-607. PubMed ID: 25194935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study).
    Stenz NA; Stampf S; Arnold AW; Cozzio A; Dickenmann M; Gaide O; Harms M; Hunger RE; Laffitte E; Mühlstädt M; Nägeli M; Hofbauer GFL;
    Dermatology; 2021; 237(6):970-980. PubMed ID: 33227788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases.
    Matin RN; Mesher D; Proby CM; McGregor JM; Bouwes Bavinck JN; del Marmol V; Euvrard S; Ferrandiz C; Geusau A; Hackethal M; Ho WL; Hofbauer GF; Imko-Walczuk B; Kanitakis J; Lally A; Lear JT; Lebbe C; Murphy GM; Piaserico S; Seckin D; Stockfleth E; Ulrich C; Wojnarowska FT; Lin HY; Balch C; Harwood CA;
    Am J Transplant; 2008 Sep; 8(9):1891-900. PubMed ID: 18786232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanomas in renal transplant recipients.
    Le Mire L; Hollowood K; Gray D; Bordea C; Wojnarowska F
    Br J Dermatol; 2006 Mar; 154(3):472-7. PubMed ID: 16445778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States.
    Garrett GL; Blanc PD; Boscardin J; Lloyd AA; Ahmed RL; Anthony T; Bibee K; Breithaupt A; Cannon J; Chen A; Cheng JY; Chiesa-Fuxench Z; Colegio OR; Curiel-Lewandrowski C; Del Guzzo CA; Disse M; Dowd M; Eilers R; Ortiz AE; Morris C; Golden SK; Graves MS; Griffin JR; Hopkins RS; Huang CC; Bae GH; Jambusaria A; Jennings TA; Jiang SI; Karia PS; Khetarpal S; Kim C; Klintmalm G; Konicke K; Koyfman SA; Lam C; Lee P; Leitenberger JJ; Loh T; Lowenstein S; Madankumar R; Moreau JF; Nijhawan RI; Ochoa S; Olasz EB; Otchere E; Otley C; Oulton J; Patel PH; Patel VA; Prabhu AV; Pugliano-Mauro M; Schmults CD; Schram S; Shih AF; Shin T; Soon S; Soriano T; Srivastava D; Stein JA; Sternhell-Blackwell K; Taylor S; Vidimos A; Wu P; Zajdel N; Zelac D; Arron ST
    JAMA Dermatol; 2017 Mar; 153(3):296-303. PubMed ID: 28097368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.
    Green AC; Baade P; Coory M; Aitken JF; Smithers M
    J Clin Oncol; 2012 May; 30(13):1462-7. PubMed ID: 22412152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
    Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
    JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous melanoma is related to immune suppression in kidney transplant recipients.
    Vajdic CM; van Leeuwen MT; Webster AC; McCredie MR; Stewart JH; Chapman JR; Amin J; McDonald SP; Grulich AE
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2297-303. PubMed ID: 19622722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience.
    Veness MJ; Quinn DI; Ong CS; Keogh AM; Macdonald PS; Cooper SG; Morgan GW
    Cancer; 1999 Apr; 85(8):1758-64. PubMed ID: 10223570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology of desmoplastic melanoma: a case-control comparison with other melanomas.
    Livestro DP; Muzikansky A; Kaine EM; Flotte TJ; Sober AJ; Mihm MC; Michaelson JS; Cosimi AB; Tanabe KK
    J Clin Oncol; 2005 Sep; 23(27):6739-46. PubMed ID: 16170181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanomas in Renal Transplant Recipients: A Single-center Study.
    Borlinić T; Knežević T; Gellineo L; Franceschi M; Bukvić Mokos Z; Bašić-Jukić N
    Acta Dermatovenerol Croat; 2017 Dec; 25(4):281-284. PubMed ID: 30064600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.